Literature DB >> 8957586

Relationship between circadian changes in renal hemodynamics and circadian changes in urinary glycosaminoglycan excretion in normal rats.

M Pons1, O Forpomès, S Espagnet, J Cambar.   

Abstract

Circadian changes in renal hemodynamics and urinary glycosaminoglycan (GAG) excretion were studied in normal Sprague-Dawley rats to further investigate rhythms in kidney function. Urinary water, protein, and GAG excretion, as well as glomerular filtration rate (GFR) and renal plasma flow (RPF), were determined every 4h over the 24h cycle in an attempt to characterize any temporal changes. Urinary flow rate and proteinuria peaked during the dark activity period of the animals, consistently at the same hour, whereas the lowest values were detected during the resting phase. GAG are mucopolysaccharides entering the constitution of the glomerular basement membrane (GBM), which is the key component in the process of glomerular filtration. Similarly, the urinary excretion rate of GAG showed a circadian rhythmicity in phase with urinary water and protein excretion, with markedly increased values observed during the nocturnal phase of the animals. Moreover, GFR and RPF were demonstrated to exhibit large circadian variations in phase with renal excretory rhythmicity, showing nighttime values significantly greater compared to daytime ones. Strong correlations were found between GFR and RPF rhythms, as well as between GAG and GFR, and GAG and RPF rhythms, although the latter were not statistically significant. This pattern suggests that the circadian rhythmicity in urinary excretion rate of GAG in physiological conditions could presumably be secondary to the temporal changes in renal hemodynamics. In this respect, knowledge of renal chronobiology helpfully contributes to increase our understanding of renal physiology.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8957586     DOI: 10.3109/07420529609012659

Source DB:  PubMed          Journal:  Chronobiol Int        ISSN: 0742-0528            Impact factor:   2.877


  8 in total

1.  Desoxycorticosterone pivalate-salt treatment leads to non-dipping hypertension in Per1 knockout mice.

Authors:  K Solocinski; M Holzworth; X Wen; K-Y Cheng; I J Lynch; B D Cain; C S Wingo; M L Gumz
Journal:  Acta Physiol (Oxf)       Date:  2016-10-03       Impact factor: 6.311

Review 2.  Chronotherapy for Hypertension.

Authors:  N P Bowles; S S Thosar; M X Herzig; S A Shea
Journal:  Curr Hypertens Rep       Date:  2018-09-28       Impact factor: 5.369

Review 3.  Circadian rhythms: from basic mechanisms to the intensive care unit.

Authors:  Ming-Cheng Chan; Peter M Spieth; Kieran Quinn; Matteo Parotto; Haibo Zhang; Arthur S Slutsky
Journal:  Crit Care Med       Date:  2012-01       Impact factor: 7.598

Review 4.  Circadian rhythms in gene expression: Relationship to physiology, disease, drug disposition and drug action.

Authors:  Siddharth Sukumaran; Richard R Almon; Debra C DuBois; William J Jusko
Journal:  Adv Drug Deliv Rev       Date:  2010-06-11       Impact factor: 15.470

Review 5.  The pathophysiology of monosymptomatic nocturnal enuresis with special emphasis on the circadian rhythm of renal physiology.

Authors:  L Dossche; J Vande Walle; C Van Herzeele
Journal:  Eur J Pediatr       Date:  2016-05-02       Impact factor: 3.183

6.  Daily variations in ceftriaxone pharmacokinetics in rats.

Authors:  M Rebuelto; L Ambros; M Rubio
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

Review 7.  The Circadian Clock in the Regulation of Renal Rhythms.

Authors:  Kristen Solocinski; Michelle L Gumz
Journal:  J Biol Rhythms       Date:  2015-11-02       Impact factor: 3.182

8.  Robust circadian clock oscillation and osmotic rhythms in inner medulla reflecting cortico-medullary osmotic gradient rhythm in rodent kidney.

Authors:  Masayuki Hara; Yoichi Minami; Munehiro Ohashi; Yoshiki Tsuchiya; Tetsuro Kusaba; Keiichi Tamagaki; Nobuya Koike; Yasuhiro Umemura; Hitoshi Inokawa; Kazuhiro Yagita
Journal:  Sci Rep       Date:  2017-08-04       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.